Esketamine with pulsed radiofrequency for shingles-related face pain
Treatments studied
Part of Brain & nervous system, Infections, Mouth & dental, Skin clinical trials.
This trial tests whether adding esketamine (a medicine related to ketamine) to a standard nerve treatment (pulsed radiofrequency) can better relieve face pain caused by shingles. It may help if you have ongoing, moderate-to-severe pain in your face or scalp.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18
- You had shingles (herpes zoster) in the past 3 months
- Your pain is in the face or scalp, where the trigeminal nerve works
- Your pain is a 4 or higher on a 0-10 scale even with pain medicine
- You plan to get a procedure called CT-guided pulsed radiofrequency (PRF) on a nerve bundle in your face (the Gasserian ganglion)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a medication called esketamine to a standard nerve procedure (pulse radiofrequency) can better reduce facial pain from shingles. Esketamine may help block pain signals more effectively.
This study tests a combination of two treatments for long-term nerve pain after shingles: a medication called esketamine and a nerve block (pulsed radiofrequency) applied to the affected spinal nerves. The goal is to see if this combination relieves the burning or shooting pain better than the nerve block alone.
This study tests whether adding a medicine called esketamine to a standard nerve block procedure can improve pain relief for people with shingles-related nerve pain. If you have had shingles pain for less than 3 months, this might help reduce pain and prevent long-term discomfort.
This trial tests whether adding esketamine to two standard pain medicines (pregabalin and duloxetine) can better treat nerve pain from shingles that persists for months. It's for people whose pain hasn't improved enough with pregabalin alone.
This trial tests a new pain medication called tulodesvenlafaxine for people with shingles-related pain. It may help if you have moderate to severe pain that started within the last 90 days.
This trial tests whether the drug venlafaxine, usually used for depression, can help prevent long-term nerve pain (postherpetic neuralgia) after a shingles infection. If you are currently experiencing shingles pain, joining this study might reduce your chances of developing chronic pain later.
Hear when a new Zoster; Herpes, Trigeminal Neuralgia (Etiology) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.